These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23706827)

  • 1. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
    BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.
    Kramná L; Dřevínek P; Lin J; Kulich M; Cinek O
    Folia Microbiol (Praha); 2018 Mar; 63(2):237-248. PubMed ID: 29127619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G; Campana S; Festini F; Mascherini M; Döring G
    Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
    Reid DW; Carroll V; O'May C; Champion A; Kirov SM
    Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?
    Deschaght P; Schelstraete P; Van Simaey L; Vanderkercken M; Raman A; Mahieu L; Van Daele S; De Baets F; Vaneechoutte M
    PLoS One; 2013; 8(11):e79010. PubMed ID: 24312174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
    Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
    Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Weiss B; Bujanover Y; Yahav Y; Vilozni D; Fireman E; Efrati O
    Pediatr Pulmonol; 2010 Jun; 45(6):536-40. PubMed ID: 20503277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
    Regelmann WE; Elliott GR; Warwick WJ; Clawson CC
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
    Smith DJ; Ramsay KA; Yerkovich ST; Reid DW; Wainwright CE; Grimwood K; Bell SC; Kidd TJ
    Respirology; 2016 Feb; 21(2):329-37. PubMed ID: 26711802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.